Endothelial retention and phenotype on carbonized cardiovascular implant surfaces

Biomaterials

Volumn 35, Issue 27, 2014, Pages 7714-7723

  Frendl, Christopher M ^a   Tucker, Scott M ^a   Khan, Nadeem A ^a   Esch, Mandy B ^a   Kanduru, Shrinidhi ^a   Cao, Thong M ^a   García, Andrés J ^b   King, Michael R ^a   Butcher, Jonathan T ^a  

^a School of Chemical and Molecular Engineering   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Adhesion peptide; Computational fluid dynamics; Hemodynamics; Hemostasis; Mechanical heart valves; Platelet adhesion

Indexed keywords

CARBON; COMPUTATIONAL FLUID DYNAMICS; DISEASES; ENDOTHELIAL CELLS; HEMODYNAMICS; LIGANDS; MONOLAYERS; NITRIC OXIDE; PROSTHETICS; SHEAR STRESS; VALVES (MECHANICAL);

CARDIOVASCULAR IMPLANTS; COMPUTATIONAL FLUID DYNAMICS SIMULATIONS; EMPIRICAL RELATIONSHIPS; ENDOTHELIAL NITRIC-OXIDE SYNTHASE (ENOS); HEMOSTASIS; MECHANICAL HEART VALVES; PLASMINOGEN ACTIVATOR INHIBITOR-1; PLATELET ADHESION;

ADHESION;

COLLAGEN TYPE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; LAMININ; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYROLYTIC CARBON; VASCULAR ENDOTHELIAL CADHERIN; CARBON; COAGULATING AGENT; LIGAND; PROTEIN; SILICON;

ADHERENT CELL; ARTICLE; CARDIOVASCULAR STENT; CELL ADHESION; CELL DENSITY; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEART VALVE PROSTHESIS; HEMODYNAMIC STRESS; HUMAN; MECHANICAL HEART VALVE; PHENOTYPE; PRIORITY JOURNAL; SHEAR STRESS; SURFACE PROPERTY; THROMBOCYTE ADHESION; VALVULAR HEART DISEASE; ADSORPTION; ANIMAL; BLOOD VESSEL PROSTHESIS; CYTOLOGY; DRUG EFFECTS; HYDRODYNAMICS; IMPLANT; MECHANICAL STRESS; METABOLISM; MICROFLUIDICS; SWINE; TEMPERATURE;

ADSORPTION; ANIMALS; BLOOD VESSEL PROSTHESIS; CARBON; CELL ADHESION; COAGULANTS; ENDOTHELIAL CELLS; HUMANS; HYDRODYNAMICS; IMPLANTS, EXPERIMENTAL; LIGANDS; MICROFLUIDICS; PHENOTYPE; PLATELET ADHESIVENESS; PROTEINS; SILICON; STRESS, MECHANICAL; SURFACE PROPERTIES; SUS SCROFA; TEMPERATURE;

EID: 84903484377     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.05.075     Document Type: Article

References (59)

1. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
2. McGuigan A.P., Sefton M.V. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 2007, 28:2547-2571.
3. Gorbet M.B., Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004, 25:5681-5703.
4. Hering D., Piper C., Horstkotte D. Drug insight: an overview of current anticoagulation therapy after heart valve replacement. Nat Clin Pract Cardiovasc Med 2005, 2:415-422.
5. Massel D.R., Little S.H. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev 2013, 7:CD003464.
6. Kaneko T., Aranki S.F. Anticoagulation for prosthetic valves. Thrombosis 2013, 2013:346752.
7. Heneghan C., Ward A., Perera R., Self-Monitoring Trialist C., Bankhead C., Fuller A., et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012, 379:322-334.
8. Grunkemeier G.L., Li H.H., Naftel D.C., Starr A., Rahimtoola S.H. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000, 25:73-154.
9. Yoshimoto Y., Hasebe T., Takahashi K., Amari M., Nagashima S., Kamijo A., et al. Ultrastructural characterization of surface-induced platelet activation on artificial materials by transmission electron microscopy. Microsc Res Tech 2013, 76:342-349.
10. Kolandaivelu K., Swaminathan R., Gibson W.J., Kolachalama V.B., Nguyen-Ehrenreich K.L., Giddings V.L., et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 2011, 123:1400-1409.
11. Levy Y., Mandler D., Weinberger J., Domb A.J. Evaluation of drug-eluting stents' coating durability-clinical and regulatory implications. JBiomed Mater Res B Appl Biomater 2009, 91:441-451.
12. Otsuka Y., Chronos N.A., Apkarian R.P., Robinson K.A. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. JInvasive Cardiol 2007, 19:71-76.
13. Milner K.R., Snyder A.J., Siedlecki C.A. Sub-micron texturing for reducing platelet adhesion to polyurethane biomaterials. JBiomed Mater Res A 2006, 76:561-570.
14. Lau K.H., Ren C., Sileika T.S., Park S.H., Szleifer I., Messersmith P.B. Surface-grafted polysarcosine as a peptoid antifouling polymer brush. Langmuir 2012, 28:16099-16107.
15. Martinez A.W., Chaikof E.L. Microfabrication and nanotechnology in stent design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:256-268.
16. Jordan S.W., Chaikof E.L. Novel thromboresistant materials. JVasc Surg 2007, 45(Suppl.A):A104-A115.
17. Otsuka F., Finn A.V., Yazdani S.K., Nakano M., Kolodgie F.D., Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 2012, 9:439-453.
18. Wu K.K., Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996, 47:315-331.
19. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. NEngl J Med 1990, 323:27-36.
20. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide Biol Chem/Official J Nitric Oxide Soc 2006, 15:265-279.
21. Wang G.R., Zhu Y., Halushka P.V., Lincoln T.M., Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide: invivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A 1998, 95:4888-4893.
22. Li J.M., Podolsky R.S., Rohrer M.J., Cutler B.S., Massie M.T., Barnard M.R., et al. Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa. JSurg Res 1996, 61:543-548.
23. Smith D., Gilbert M., Owen W.G. Tissue plasminogen activator release invivo in response to vasoactive agents. Blood 1985, 66:835-839.
24. Murata M., Ikeda Y., Araki Y., Murakami H., Sato K., Yamamoto M., et al. Inhibition by endothelial cells of platelet aggregating activity of thrombin-role of thrombomodulin. Thromb Res 1988, 50:647-656.
25. Fujii S., Sawa H., Saffitz J.E., Lucore C.L., Sobel B.E. Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis invivo. Circulation 1992, 86:2000-2010.
26. Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009, 16:209-221.
27. Ensley A.E., Nerem R.M., Anderson D.E., Hanson S.R., Hinds M.T. Fluid shear stress alters the hemostatic properties of endothelial outgrowth cells. Tissue Eng Part A 2012, 18:127-136.
28. Bergh N., Larsson P., Ulfhammer E., Jern S. Effect of shear stress, statins and TNF-alpha on hemostatic genes in human endothelial cells. Biochem Biophys Res Commun 2012, 420:166-171.
29. Douglas G., Van Kampen E., Hale A.B., McNeill E., Patel J., Crabtree M.J., et al. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. Eur Heart J 2013, 34:3378-3388.
30. Zilla P., Bezuidenhout D., Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007, 28:5009-5027.
31. Meyers S.R., Kenan D.J., Khoo X., Grinstaff M.W. Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion. Biomacromolecules 2011, 12:533-539.
32. Lu J., Rao M.P., MacDonald N.C., Khang D., Webster T.J. Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater 2008, 4:192-201.
33. Samijo S.K., Willigers J.M., Barkhuysen R., Kitslaar P.J., Reneman R.S., Brands P.J., et al. Wall shear stress in the human common carotid artery as function of age and gender. Cardiovasc Res 1998, 39:515-522.
34. Woo Y.R., Yoganathan A.P. Invitro pulsatile flow velocity and shear stress measurements in the vicinity of mechanical mitral heart valve prostheses. JBiomech 1986, 19:39-51.
35. Levesque M.J., Nerem R.M. The elongation and orientation of cultured endothelial cells in response to shear stress. JBiomech Eng 1985, 107:341-347.
36. Bengtsson L.A., Haegerstrand A.N. Endothelialization of mechanical heart valves invitro with cultured adult human cells. JHeart Valve Dis 1993, 2:352-356.
37. Garcia A.J., Gallant N.D. Stick and grip: measurement systems and quantitative analyses of integrin-mediated cell adhesion strength. Cell Biochem Biophys 2003, 39:61-73.
38. Wojtowicz A.M., Shekaran A., Oest M.E., Dupont K.M., Templeman K.L., Hutmacher D.W., et al. Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials 2010, 31:2574-2582.
39. Petrie T.A., Capadona J.R., Reyes C.D., Garcia A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 2006, 27:5459-5470.
40. Gould R.A., Butcher J.T. Isolation of valvular endothelial cells. JVis Exp Dec. 29 2010, 46.
41. Butcher J.T., Penrod A.M., Garcia A.J., Nerem R.M. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol 2004, 24:1429-1434.
42. Reyes C.D., Petrie T.A., Garcia A.J. Mixed extracellular matrix ligands synergistically modulate integrin adhesion and signaling. JCell Physiol 2008, 217:450-458.
43. Reyes C.D., Garcia A.J. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide. JBiomed Mater Res A 2003, 65:511-523.
44. Butcher J.T., Nerem R.M. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng 2006, 12:905-915.
45. Spinelli S.L., Casey A.E., Pollock S.J., Gertz J.M., McMillan D.H., Narasipura S.D., et al. Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 2010, 30:591-598.
46. Weston M.W., LaBorde D.V., Yoganathan A.P. Estimation of the shear stress on the surface of an aortic valve leaflet. Ann Biomed Eng 1999, 27:572-579.
47. Yap C.H., Saikrishnan N., Yoganathan A.P. Experimental measurement of dynamic fluid shear stress on the ventricular surface of the aortic valve leaflet. Biomech Model Mechanobiol 2012, 11:231-244.
48. Barreto-Filho J.A., Wang Y., Dodson J.A., Desai M.M., Sugeng L., Geirsson A., et al. Trends in aortic valve replacement for elderly patients in the United States, 1999-2011. JAm Med Assoc 2013, 310:2078-2085.
49. Northrup W.F., Dubois K.A., Kshettry V.R., Teskey J.M., Nicoloff D.M. Trends in aortic valve surgery in a large multi-surgeon, multi-hospital practice, 1979-1999. JHeart Valve Dis 2002, 11:768-778. [discussion 78-9].
50. Niclauss L., von Segesser L.K., Ferrari E. Aortic biological valve prosthesis in patients younger than 65 years of age: transition to a flexible age limit?. Interact Cardiovasc Thorac Surg 2013, 16:501-507.
51. David T.E., David C., Woo A., Manlhiot C. The Ross procedure: outcomes at 20 years. JThorac Cardiovasc Surg 2014, 147:85-93.
52. Zilla P., Brink J., Human P., Bezuidenhout D. Prosthetic heart valves: catering for the few. Biomaterials 2008, 29:385-406.
53. McIntosh C.T., Warnock J.N. Side-specific characterization of aortic valve endothelial cell adhesion molecules under cyclic strain. JHeart Valve Dis 2013, 22:631-639.
54. Chlupac J., Filova E., Havlikova J., Matejka R., Riedel T., Houska M., et al. The gene expression of human endothelial cells is modulated by sub-endothelial extracellular matrix proteins: short-term response to laminar shear stress. Tissue Eng Part A April 24 2014, [Epub ahead of print].
55. Thoumine O., Nerem R.M., Girard P.R. Changes in organization and composition of the extracellular matrix underlying cultured endothelial cells exposed to laminar steady shear stress. Lab Invest 1995, 73:565-576.
56. Jang Y.H., Kwon C.H., Kim S.B., Selimovic S., Sim W.Y., Bae H., et al. Deep wells integrated with microfluidic valves for stable docking and storage of cells. Biotechnol J 2011, 6:156-164.
57. Polanowska-Grabowska R., Simon C.G., Gear A.R. Platelet adhesion to collagen type I, collagen type IV, von Willebrand factor, fibronectin, laminin and fibrinogen: rapid kinetics under shear. Thromb Haemost 1999, 81:118-123.
58. Higuchi A., Sugiyama K., Yoon B.O., Sakurai M., Hara M., Sumita M., et al. Serum protein adsorption and platelet adhesion on pluronic-adsorbed polysulfone membranes. Biomaterials 2003, 24:3235-3245.
59. Tan A., Goh D., Farhatnia Y., Lim J., G N., Teoh S.H., et al. An anti-CD34 antibody-functionalized clinical-grade POSS-PCU nanocomposite polymer for cardiovascular stent coating applications: a preliminary assessment of endothelial progenitor cell capture and hemocompatibility. PLoS One 2013, 8:e77112.